Business
Why the Race Oncology (ASX:RAC) share price is racing higher
The Race Oncology Ltd (ASX: RAC) share price is climbing today after an update from the Aussie healthcare company.
Why is the Race Oncology share price climbing?
Race Oncology announced that it has entered into a collaborative preclinical research program with The University of Newcastle. The purpose of the program is to investigate the heart safety Bisantrene offers over current anthracycline therapeutics.
Bisantrene is Race Oncology’s Phase 2/3 cancer drug that is a “potent inhibitor” of the Fatso/Fat mass and obesity-associated (FTO) protein. The possible role of FTO inhibition in Bisantrene’s lack of cardiotoxicity will be a primary focus of the new project.
The Race Oncology share price has jumped 1.6% higher at…
-
General14 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
General17 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
Noosa News18 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’
-
Noosa News24 hours agoRoaring jet boats to return to Victoria for first time in 15 years